Posted by Michael Wonder on 20 Aug 2025
Altimmune announces FDA fast track designation for pemvidutide in alcohol use disorder
19 August 2025 -Â Pemvidutide is the only drug currently granted fast track designation in AUD.
Altimmune today announced that the US FDA has granted fast track designation to pemvidutide for the treatment of alcohol use disorder.
